The expression of cytochrome P450IIB1 in saccharomyces cerevisia results in an increased mutation frequency when exposed to cyclophosphamide

Stephen Matthew Black, Sian Ellard, Richard R. Meehan, James M. Parry, Milton Adesnik, Jean D. Beggs, C. Roland Wolf

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

A recombinant plasmid containing a full length cDNA encoding the rat cytochrome P450IIB1 under the control of the Saccharomyces cerevisiae ADC1 promoter was constructed and transformed into the yeast strain KYI 118. The encoded P450IIB1 protein was produced at a level of between 0.1 and 0.2% of total yeast cellular protein (0.068 nmol/mg total cellular protein). This protein was localized in the mkrosomal fraction and had activity towards the substrate benzyloxy-resorufin, the activity being 0.16 nmol resorufin produced/ min/mg microsomal protein. When exposed to the anticancer drug cyclophosphamide the mutation frequency, as determined by the development of resistance to the arginine analogue canavanine, increased in a dose-dependent manner over a control strain and was up to 16-fold higher at the highest doses used.

Original languageEnglish (US)
Pages (from-to)2139-2143
Number of pages5
JournalCarcinogenesis
Volume10
Issue number11
DOIs
StatePublished - Nov 1 1989

Fingerprint

Mutation Rate
Cytochromes
Cyclophosphamide
Saccharomyces cerevisiae
Proteins
Canavanine
Fungal Proteins
Arginine
Plasmids
Complementary DNA
Yeasts
Pharmaceutical Preparations
resorufin

ASJC Scopus subject areas

  • Cancer Research

Cite this

The expression of cytochrome P450IIB1 in saccharomyces cerevisia results in an increased mutation frequency when exposed to cyclophosphamide. / Black, Stephen Matthew; Ellard, Sian; Meehan, Richard R.; Parry, James M.; Adesnik, Milton; Beggs, Jean D.; Wolf, C. Roland.

In: Carcinogenesis, Vol. 10, No. 11, 01.11.1989, p. 2139-2143.

Research output: Contribution to journalArticle

Black, Stephen Matthew ; Ellard, Sian ; Meehan, Richard R. ; Parry, James M. ; Adesnik, Milton ; Beggs, Jean D. ; Wolf, C. Roland. / The expression of cytochrome P450IIB1 in saccharomyces cerevisia results in an increased mutation frequency when exposed to cyclophosphamide. In: Carcinogenesis. 1989 ; Vol. 10, No. 11. pp. 2139-2143.
@article{e8d09baf7b24474cb56406b37388b855,
title = "The expression of cytochrome P450IIB1 in saccharomyces cerevisia results in an increased mutation frequency when exposed to cyclophosphamide",
abstract = "A recombinant plasmid containing a full length cDNA encoding the rat cytochrome P450IIB1 under the control of the Saccharomyces cerevisiae ADC1 promoter was constructed and transformed into the yeast strain KYI 118. The encoded P450IIB1 protein was produced at a level of between 0.1 and 0.2{\%} of total yeast cellular protein (0.068 nmol/mg total cellular protein). This protein was localized in the mkrosomal fraction and had activity towards the substrate benzyloxy-resorufin, the activity being 0.16 nmol resorufin produced/ min/mg microsomal protein. When exposed to the anticancer drug cyclophosphamide the mutation frequency, as determined by the development of resistance to the arginine analogue canavanine, increased in a dose-dependent manner over a control strain and was up to 16-fold higher at the highest doses used.",
author = "Black, {Stephen Matthew} and Sian Ellard and Meehan, {Richard R.} and Parry, {James M.} and Milton Adesnik and Beggs, {Jean D.} and Wolf, {C. Roland}",
year = "1989",
month = "11",
day = "1",
doi = "10.1093/carcin/10.11.2139",
language = "English (US)",
volume = "10",
pages = "2139--2143",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - The expression of cytochrome P450IIB1 in saccharomyces cerevisia results in an increased mutation frequency when exposed to cyclophosphamide

AU - Black, Stephen Matthew

AU - Ellard, Sian

AU - Meehan, Richard R.

AU - Parry, James M.

AU - Adesnik, Milton

AU - Beggs, Jean D.

AU - Wolf, C. Roland

PY - 1989/11/1

Y1 - 1989/11/1

N2 - A recombinant plasmid containing a full length cDNA encoding the rat cytochrome P450IIB1 under the control of the Saccharomyces cerevisiae ADC1 promoter was constructed and transformed into the yeast strain KYI 118. The encoded P450IIB1 protein was produced at a level of between 0.1 and 0.2% of total yeast cellular protein (0.068 nmol/mg total cellular protein). This protein was localized in the mkrosomal fraction and had activity towards the substrate benzyloxy-resorufin, the activity being 0.16 nmol resorufin produced/ min/mg microsomal protein. When exposed to the anticancer drug cyclophosphamide the mutation frequency, as determined by the development of resistance to the arginine analogue canavanine, increased in a dose-dependent manner over a control strain and was up to 16-fold higher at the highest doses used.

AB - A recombinant plasmid containing a full length cDNA encoding the rat cytochrome P450IIB1 under the control of the Saccharomyces cerevisiae ADC1 promoter was constructed and transformed into the yeast strain KYI 118. The encoded P450IIB1 protein was produced at a level of between 0.1 and 0.2% of total yeast cellular protein (0.068 nmol/mg total cellular protein). This protein was localized in the mkrosomal fraction and had activity towards the substrate benzyloxy-resorufin, the activity being 0.16 nmol resorufin produced/ min/mg microsomal protein. When exposed to the anticancer drug cyclophosphamide the mutation frequency, as determined by the development of resistance to the arginine analogue canavanine, increased in a dose-dependent manner over a control strain and was up to 16-fold higher at the highest doses used.

UR - http://www.scopus.com/inward/record.url?scp=0024467889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024467889&partnerID=8YFLogxK

U2 - 10.1093/carcin/10.11.2139

DO - 10.1093/carcin/10.11.2139

M3 - Article

C2 - 2680147

AN - SCOPUS:0024467889

VL - 10

SP - 2139

EP - 2143

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 11

ER -